|
MASTL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.450400E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.981700E-02 |
| Normal-vs-Stage2 |
2.988800E-01 |
| Normal-vs-Stage3 |
5.378800E-01 |
| Normal-vs-Stage4 |
1.498580E-01 |
| Stage1-vs-Stage2 |
8.252000E-01 |
| Stage1-vs-Stage3 |
1.044580E-03 |
| Stage1-vs-Stage4 |
7.559000E-01 |
| Stage2-vs-Stage3 |
1.525250E-01 |
| Stage2-vs-Stage4 |
9.925200E-01 |
| Stage3-vs-Stage4 |
4.329700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.487960E-01 |
| Normal-vs-AfricanAmerican |
5.536500E-02 |
| Normal-vs-Asian |
7.028200E-01 |
| Caucasian-vs-AfricanAmerican |
2.032800E-01 |
| Caucasian-vs-Asian |
9.124800E-01 |
| AfricanAmerican-vs-Asian |
5.716600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.227800E-01 |
| Normal-vs-Female |
4.108100E-02 |
| Male-vs-Female |
2.586600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.658590E-01 |
| Normal-vs-Age(41-60Yrs) |
2.507800E-02 |
| Normal-vs-Age(61-80Yrs) |
4.530800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.600200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.047800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.619400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.543240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.624300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.573640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.437200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.07499999999428E-05 |
| Normal-vs-Grade 2 |
1.923790E-02 |
| Normal-vs-Grade 3 |
5.276200E-01 |
| Normal-vs-Grade 4 |
9.511600E-01 |
| Grade 1-vs-Grade 2 |
3.181700E-02 |
| Grade 1-vs-Grade 3 |
7.590000E-04 |
| Grade 1-vs-Grade 4 |
3.436500E-03 |
| Grade 2-vs-Grade 3 |
3.954000E-02 |
| Grade 2-vs-Grade 4 |
7.714300E-02 |
| Grade 3-vs-Grade 4 |
6.480600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.963700E-03 |
| Normal-vs-ccB subtype |
9.625200E-01 |
| ccA subtype-vs-ccB subtype |
2.555900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.716770E-01 |
| Normal-vs-N1 |
8.094100E-02 |
| N0-vs-N1 |
1.938560E-01 |
|
|
